Blend

IGF-LR3/MOTS-c

IGF-1 LR3 + MOTS-C

A strategic combination of IGF-1 LR3 for anabolic signaling and MOTS-C for mitochondrial optimization. This blend delivers sustained muscle growth through direct IGF-1 receptor activation while enhancing cellular energy production, metabolic flexibility, and recovery capacity—addressing both muscle protein synthesis and the energetic demands of performance.

The Science

What is Blend IGF-LR3/MOTS-c?

This advanced peptide blend combines IGF-1 LR3, a long-acting insulin-like growth factor analog, with MOTS-C, a mitochondrial-encoded peptide that regulates cellular metabolism.

IGF-1 LR3 provides sustained muscle protein synthesis and satellite cell activation through direct IGF-1 receptor engagement, while MOTS-C enhances mitochondrial function, improves insulin sensitivity, and supports metabolic flexibility. This dual mechanism supports muscle growth while optimizing the cellular energy systems required for performance and recovery.

The combination is particularly effective for individuals seeking comprehensive body composition optimization—promoting lean muscle gain through anabolic pathways while enhancing fat metabolism and energy production through mitochondrial enhancement.

Laboratory Observations

Key Observed Effects of IGF-LR3/MOTS-c

Enhanced Muscle Growth

IGF-1 LR3 drives rapid muscle protein synthesis and hypertrophy while MOTS-C ensures adequate cellular energy to support sustained anabolic activity and training intensity.

Improved Recovery

Dual support for muscle repair through IGF-1 receptor pathways and enhanced mitochondrial ATP production accelerates recovery between training sessions and reduces fatigue.

Metabolic Optimization

MOTS-C enhances insulin sensitivity and glucose metabolism while improving fat oxidation—supporting lean mass gains with improved nutrient partitioning and body composition.

Increased Energy & Endurance

Mitochondrial enhancement from MOTS-C increases cellular ATP production and oxidative capacity, supporting improved exercise performance and sustained energy throughout training.

Cellular Health Support

MOTS-C provides protective effects on mitochondria while supporting metabolic health markers including improved insulin sensitivity, glucose regulation, and reduced oxidative stress.

Mechanism of Action

Dual-Pathway Enhancement

This blend activates both anabolic and metabolic pathways—IGF-1 LR3 drives muscle protein synthesis while MOTS-C optimizes mitochondrial function for enhanced energy production and metabolic health.

1

IGF-1 Receptor Activation

IGF-1 LR3 binds to muscle IGF-1 receptors, triggering PI3K/Akt and MAPK pathways that promote protein synthesis, satellite cell proliferation, and muscle hypertrophy.

2

Mitochondrial Optimization

MOTS-C regulates mitochondrial function, improves oxidative phosphorylation efficiency, and enhances cellular ATP production for sustained energy and recovery.

3

Metabolic Flexibility

MOTS-C enhances insulin sensitivity and glucose metabolism while IGF-1 LR3 increases nutrient partitioning to muscle—creating optimal conditions for lean mass gains and fat utilization.

FAQ

Frequently Asked Questions

Why combine IGF-1 LR3 with MOTS-C?+

This combination addresses both anabolic signaling and metabolic function. IGF-1 LR3 drives muscle protein synthesis and growth while MOTS-C optimizes mitochondrial efficiency and energy production. Together, they create a synergistic effect—building muscle while ensuring the cells have the metabolic capacity to support that growth, recovery, and performance.

When do results appear in this blend studies?+

Users typically report accelerated muscle growth, improved energy levels and endurance, enhanced recovery between sessions, better body composition with lean mass gains, increased training capacity, and improved metabolic markers. Results are maximized when combined with proper training, nutrition, and adequate protein intake. Individual responses vary based on training status, diet, genetics, and baseline metabolic health.

Research-Only Notice

IGF-LR3/MOTS-c is categorized by the FDA as for research-purposes-only. It is not intended for human consumption, diagnosis, treatment, cure, or prevention of any disease. The information above summarizes effects observed in laboratory studies to date and is provided strictly for scientific and educational reference.